News
All EMBL-EBI news
Research highlights
The PROTACtable genome – a new route to drug discovery
Artist's impression of the proteasome targeting proteins for degradation. Credit: Karen Arnott/EMBL-EBI
Tags:
Andrew Leach
,
drug discovery
,
drug targets
,
Industry
,
open access
,
Open Targets
,
Share this
More Research highlights
Predicting cancer risk on the basis of national health data
23 May 2024
‘Exhausted’ immune cells in healthy women could be target for breast cancer prevention
28 March 2024
Unravelling the role of immune cells in early lung development
20 December 2023
ggCaller: The next step in scaling up bacterial genome annotation
16 October 2023